The FDA cleared the first insulin management mobile app for marketing this week, developer Hygieia announced.
Along with the Agency for Toxic Substances and Disease Registry, the CDC announced plans to evaluate per- and polyfluoroalkyl substances (PFAS) exposure near military bases starting this year.
Researchers at Mount Sinai identified certain DNA variants that determine fat distribution — like a predisposition to a pear versus apple shape. Watch lead author Ruth Loos, PhD, of the Icahn School of Medicine, discuss the findings here. (Nature Genetics)
According to three real-world studies presented at the Advanced Technologies & Treatments for Diabetes (ATTD) meeting, Abbott’s FreeStyle Libre flash glucose monitoring system showed a 56% reduction in the likelihood of prolonged hypoglycemia, among other benefits.
The American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) released the 2019 update to their comprehensive type 2 diabetes management algorithm. (Endocrine Practice)
Rather than a blood test, luteinizing hormone pulse patterns could instead be assessed robotically to diagnose fertility problems. (Nature Communications)
Tight versus lax glucose control for pregnant women with gestational diabetes might bear little to no consequence on neonatal glucose levels, according to a study presented at the Society for Maternal-Fetal Medicine (SMFM) meeting. Catch up on all of MedPage Today‘s SMFM coverage here.
Warning to people with osteoporosis: avoid certain yoga positions, like ones that compress the spine. (Mayo Clinic Proceedings)